By Jacqueline Bell ( December 3, 2007, 12:00 AM EST) -- King Pharmaceuticals, Inc. revealed Monday that a federal appeals court has nixed its bid for a rehearing in a patent dispute over its top-selling hypertension medicine....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.